Atjaunināt sīkdatņu piekrišanu

E-grāmata: Foot in Diabetes 5th Edition 5th Edition [Wiley Online]

Edited by (University of Manchester, UK), Edited by (University of Texas Southwestern, Dallas, Texas, USA), Edited by (East Suffolk and North Essex NHS Foundation Trust, UK)
  • Formāts: 568 pages
  • Sērija : Practical Diabetes
  • Izdošanas datums: 11-Jun-2020
  • Izdevniecība: Wiley-Blackwell
  • ISBN-10: 1119445825
  • ISBN-13: 9781119445821
Citas grāmatas par šo tēmu:
  • Wiley Online
  • Cena: 164,95 €*
  • * this price gives unlimited concurrent access for unlimited time
Foot in Diabetes 5th Edition 5th EditionPalielināt
  • Formāts: 568 pages
  • Sērija : Practical Diabetes
  • Izdošanas datums: 11-Jun-2020
  • Izdevniecība: Wiley-Blackwell
  • ISBN-10: 1119445825
  • ISBN-13: 9781119445821
Citas grāmatas par šo tēmu:
Wiley Online E-booksMore info about Wiley Online
Rokasgrāmatas mājas lapa: https://onlinelibrary.wiley.com/doi/book/10.1002/9781119445821
"Since the publication of the last edition, there have been important developments in the field of diabetic foot care and its scientific basis. All of these developments are reviewed in the book, with a focus on practical applications and management. Diabetic foot problems are among the most important long-term consequences of diabetes. They can be a major cause of disablement and impose a serious economic burden on healthcare organisations"--

Fully revised and updated edition of this popular book, addressing all issues concerning the diabetic foot, one of the most prevalent problems in diabetes, with a strong emphasis on practical aspects of delivering care.

List of Contributors xv
Preface xix
Introduction xxi
1 Epidemiology and Economic Impact of Foot Ulcers 1(16)
Edward J. Boyko
Matilde Monteiro-Soares
1.1 Introduction
1(1)
1.2 Diabetic Foot Ulcer (DFU) Definition
1(1)
1.3 DFU Classification
2(1)
1.4 DFU Incidence and Prevalence
3(2)
1.5 DFU Recurrence
5(1)
1.6 Risk Factors for Diabetic Foot Ulcers and Lower Extremity Amputation
6(1)
1.7 Diabetic Foot Ulcer Outcomes
7(2)
1.8 Economic Considerations
9(1)
References
10(7)
2 Cost of Diabetic Foot Disease in England 17(14)
Marion Kerr
2.1 Introduction
17(1)
2.2 Human Costs
17(3)
2.3 Financial Costs
20(2)
2.4 Why Measure Costs?
22(1)
2.5 Establishing Healthcare Priorities
22(3)
2.6 Conclusions
25(1)
References
26(5)
3 Epidemiology of Amputation and the Influence of Ethnicity 31(12)
Caroline A. Abbott
3.1 Why Study the Epidemiology of LEA?
31(1)
3.2 LEA Incidence Study Design: The Risk of Bias
32(1)
3.3 LEA Risk Assessment Study Design
32(1)
3.4 Risk Factors for LEA
33(1)
3.5 Incidence Rates of LEA
34(1)
3.6 International and Regional Differences
34(1)
3.7 Time Trends in LEA Rates
34(1)
3.8 Ethnic Differences in Diabetes-Related LEA
35(1)
3.9 Ethnic Differences in Diabetes-Related LEA Risk
35(3)
3.10 Indian Asians
38(1)
References
38(5)
4a The Diabetic Foot Worldwide: India 43(4)
M. Viswanathan
4a.1 Introduction
43(1)
4a.2 Epidemiology of Diabetes in India
43(1)
4a.3 Socio Economic Burden Due to Diabetes
43(1)
4a.4 Common Risk Factors for Amputation in India
43(1)
4a.5 Diagnosing High Risk Feet in Developing Countries
44(1)
4a.6 Comparison in Risk Factors between India and the Western World
44(1)
4a.7 DFI as a Cause for Declining Kidney Function
44(1)
4a.8 Helping People with Amputation Cope Up with the Disability
44(1)
References
45(2)
4b The Diabetic Foot Worldwide: Pakistan 47(4)
Abdul Basit
4b.1 Introduction
47(1)
4b.2 Concept of Multidisciplinary Diabetic Foot Care Team (MDFCT)
47(1)
4b.3 Nationwide Diabetic Foot Programme (Step by Step4SbS1)
48(1)
4b.4 Footwear for Every Diabetic (FED)
48(1)
4b.5 Further Steps Ahead of SbS
49(1)
References
49(2)
4c The Diabetic Foot Worldwide: Sub-Saharan Africa 51(10)
Zulfiqarali G. Abbas
4c.1 Introduction
51(1)
4c.2 Pathophysiology of Foot Ulcers
52(1)
4c.3 Peripheral Neuropathy (PN)
52(1)
4c.4 Peripheral Arterial Diseases (PAD)
53(1)
4c.5 Foot Ulceration in SSA
54(1)
4c.6 Foot Infection
55(1)
4c.7 Amputation
56(1)
4c.8 Mortality
56(1)
4c.9 Prevention
56(2)
4c.10 Conclusions
58(1)
References
58(3)
4d Burden of Diabetic Foot Disease in Brazil 61(6)
Hermelinda C. Pedrosa
Luciana R. Bahia
References
64(3)
4e Diabetic Foot in Romania and Eastern Europe 67(8)
Norina Alinta Govan
C.I. Bondor
4e.1 Introduction
67(1)
4e.2 The Aim
67(1)
4e.3 Diabetic Foot in Romania
67(3)
4e.4 Diabetic Foot in Eastern Europe
70(1)
4e.5 Conclusions
71(1)
References
71(4)
4f Diabetic Foot Worldwide: Pacific Region 75(4)
Shigeo Kono
References
76(3)
4g The Diabetic Foot Worldwide: Middle East 79(6)
Samir H. Assaad-Khalil
4g.1 The Burden of Diabetic Foot Disease (DFD) in the Middle East (ME)
79(1)
4g.2 Specific Regional Barriers to Healthy Feet and Foot Care
80(1)
4g.3 Misconceptions
81(1)
4g.4 Footwear
81(1)
4g.5 Foot Care, Education and Awareness
81(1)
References
82(3)
4h The Diabetic Foot Worldwide: Australasia 85(4)
Peter A. Lazzarini
4h.1 Introduction
85(1)
4h.2 Australia
85(1)
4h.3 New Zealand
86(1)
4h.4 Pacific Islands
86(1)
4h.5 Conclusion
87(1)
References
87(2)
5 Diabetic Neuropathy 89(16)
Dinesh Selvarajah
Gordon Sloan
Solomon Tesfaye
5.1 Epidemiology
89(1)
5.2 Classification
89(2)
5.3 Symmetrical Neuropathies
91(4)
5.4 Asymmetrical Neuropathies
95(2)
5.5 Pathogenesis of Distal Symmetrical Neuropathy
97(1)
5.6 Management of Diabetic Neuropathy
98(3)
References
101(4)
6 The Pathway to Ulceration: Aetiopathogenesis and Screening 105(20)
Andrew J.M. Boulton
6.1 Introduction
105(1)
6.2 Peripheral Arterial Disease (PAD)
106(1)
6.3 Diabetic Neuropathy
107(2)
6.4 Neuropathy: The Major Contributory Factor in Ulceration
109(1)
6.5 Other Risk Factors for Foot Ulceration
109(2)
6.6 Assessment of Foot Ulcer Risk
111(5)
6.7 The Pathway to Ulceration
116(2)
6.8 Mechanical Factors and Neuropathic Foot Ulceration
118(2)
6.9 The Patient with Sensory Loss
120(1)
References
120(5)
7 Biomechanics of the Diabetic Foot for the Uninitiated 125(14)
S.A. Bus
J.S. Ulbrecht
7.1 Introduction
125(1)
7.2 The Concept of Pressure and its Measurement
125(1)
7.3 The Role of Elevated Plantar Pressure in Foot Ulceration
126(2)
7.4 Mechanisms of Elevated Plantar Pressure
128(2)
7.5 Foot Biomechanics in Treating a Plantar Foot Ulcer
130(2)
7.6 Biomechanical Issues in Preventing a Foot Ulcer
132(1)
7.7 Summary
133(1)
References
134(5)
8 Psychological and Behavioural Aspects of Diabetic Foot Ulceration 139(14)
Loretta Vileikyte
Ryan T. Crews
8.1 The Role of Psychological and Behavioural Factors in DFU Development
139(3)
8.2 The Role of Psychological and Behavioural Factors in DFU Healing
142(4)
8.3 The Impact of DFUs on Patients' Health Status and QoL
146(1)
8.4 Measuring QoL in DFU Patients: Generic, DFU-Specific or Combined Approach?
147(1)
References
148(5)
9 What Role for the Plain Radiograph of the Diabetic Foot? 153(16)
Richard William Whitehouse
9.1 Introduction
153(4)
9.2 Pathologies
157(9)
9.3 Summary
166(1)
References
167(2)
10 Advanced Cross-Sectional Radiology-Ultrasound, Computed Tomography and Magnetic Resonance Imaging of the Diabetic Foot 169(18)
Aparna Komarraju
Avneesh Chhabra
10.1 Introduction
169(1)
10.2 Pathophysiology of Diabetic Foot Disease
170(13)
References
183(4)
11 Gait and Exercise Training in Diabetic Peripheral Neuropathy 187(14)
Neil D. Reeves
11.1 Introduction
187(1)
11.2 Gait Characteristics of People with Diabetes
187(1)
11.3 Muscle Forces and the Biomechanics of Gait in Diabetes
188(2)
11.4 Biomechanical Strategies to Alter Gait in Diabetic Peripheral Neuropathy
190(3)
11.5 Falls and Diabetic Peripheral Neuropathy
193(1)
11.6 Biomechanical Factors Leading to Increased Fall Risk
193(1)
11.7 Diabetic Peripheral Neuropathy and Balance during Gait
194(2)
11.8 Exercise and Diabetic Peripheral Neuropathy
196(1)
11.9 Effects of Exercise in Patients with Diabetic Peripheral Neuropathy on Gait and Balance
197(1)
11.10 The Case for Resistance Exercise Training
198(1)
References
198(3)
12 Smart Technology for the Diabetic Foot in Remission 201(24)
Bijan Najafi
David G. Armstrong
12.1 Background
201(2)
12.2 Technologies to Guide the Prescription of Footwear-Related Offloading Treatments
203(1)
12.3 Technologies to Facilitate Triaging those at High Risk of DFU
204(7)
12.4 Technologies to Manage Dose of Physical Activities in People with Diabetes and Insensate Foot
211(3)
12.5 Using Technology to Improve Patient Education for Effective Prevention of Diabetic Foot Ulcers
214(1)
12.6 Mobile Health (mHealth) to Manage Diabetic Foot Ulcers
215(1)
12.7 Internet of Things and Remote Management of Diabetic Foot Ulcers
216(1)
12.8 Technologies to Facilitate Delivering of Therapy at Home and Reduce Risk of DFU
217(1)
12.9 Conclusion
218(1)
References
219(6)
13 How to Assess the Quality of Clinical Trials for Diabetic Foot Ulcer Therapies 225(10)
Fran Game
William Jeffcoate
13.1 Introduction
225(1)
13.2 Hierarchy of Evidence
226(1)
13.3 Items to Be Considered in Assessing Trials of Diabetic Foot Ulcer Therapies
227(1)
13.4 The Population
227(1)
13.5 The Person and Limb
228(1)
13.6 The Ulcer
229(1)
13.7 The Therapy
230(1)
13.8 Outcomes
230(1)
13.9 Adverse Events
231(1)
13.10 21 Point Checklist
231(2)
References
233(2)
14a Bypass in Diabetic Peripheral Artery Disease 235(12)
Neal R. Barshes
Joseph L. Mills
14a.1 Identifying Significant PAD Amongst Patients Presenting with Foot Ulcers
235(2)
14a.2 Relative Benefits and Risks: Identifying Patients Who May Benefit from a Leg Bypass Operation
237(2)
14a.3 Evaluating Relevant Vascular Anatomy for Planning a Bypass Operation
239(2)
14a.4 The Operation and Early In-Hospital Recovery
241(2)
14a.5 Follow-Up After a Leg Bypass Operation
243(1)
References
243(4)
14b Surgery or Endovascular Intervention in Diabetic Peripheral Vascular Disease 247(12)
Edward Y. Woo
Misaki M. Kiguchi
14b.1 Introduction
247(1)
14b.2 Background
247(1)
14b.3 Diagnosis
248(2)
14b.4 Management
250(1)
14b.5 Endovascular Revascularization
250(3)
14b.6 Results
253(1)
14b.7 Complications
254(1)
14b.8 Conclusion
254(1)
References
255(4)
15 Inpatient Diabetic Foot Care: A UK Perspective 259(6)
Gerry Rayman
15.1 Introduction
259(1)
15.2 The Burden of Inpatient Diabetes
260(1)
15.3 The Burden of Inpatient Diabetic Foot Disease
260(1)
15.4 Recommended Foot Care for Inpatients with Diabetes
261(1)
15.5 Summary
262(1)
References
263(2)
16 Diagnosis and Management of Infection in the Diabetic Foot 265(22)
Edgar J.G. Peters
Benjamin A. Lipsky
16.1 Introduction
265(1)
16.2 Pathophysiology of Infections in Persons with Diabetes Mellitus
265(1)
16.3 Risk Factors for DFI
266(1)
16.4 Clinical Signs and Symptoms
266(1)
16.5 Classification
267(1)
16.6 Microbiology
268(1)
16.7 Treatment
269(5)
16.8 IWGDF Grade 4 (Severe) Infections
274(1)
16.9 Osteomyelitis
275(5)
References
280(7)
17 Surgical Approach to Diabetic Foot Infections 287(14)
Katherine M. Raspovic
Javier La Fontaine
Lawrence Lavery
17.1 Introduction
287(1)
17.2 Initial Evaluation
288(2)
17.3 Initial Surgical Intervention
290(3)
17.4 After Initial Surgical Intervention
293(1)
17.5 Staged Surgical Intervention and Wound Closure
294(2)
17.6 Surgical Offloading
296(1)
17.7 Soft Tissue/Tendon Balancing and Definitive Osseous Surgical Reconstruction
296(1)
17.8 Decision for Proximal Level Amputation
297(1)
17.9 Conclusions
298(1)
References
298(3)
18 The Evidence Base for the Choice of Dressings in the Management of Diabetic Foot Ulcers 301(10)
William J. Jeffcoate
Patricia E. Price
Frances L. Game
18.1 The Problems
301(1)
18.2 Quality of Evidence
302(1)
18.3 The Definition of a Dressing
302(1)
18.4 The Roles of the Dressing
303(1)
18.5 Basic Aspects of Wound Care
304(1)
18.6 Evidence for Potential Contributions of Dressings and Wound Applications to Improve Wound Healing
304(2)
18.7 Other Therapies which May Modulate Healing of Chronic Wounds
306(1)
18.8 Summary
307(1)
References
308(3)
19 Pathogenesis of Charcot Neuroarthropathy and Acute Management 311(12)
N.L. Petrova
Michael E. Edmonds
19.1 Introduction
311(1)
19.2 Pathogenesis of CN
311(5)
19.3 Acute Management of CN
316(2)
19.4 Conclusions
318(1)
References
319(4)
20 Surgical Reconstruction of the Charcot Foot 323(22)
George Liu
Katherine Raspovic
Dane Wukich
20.1 Introduction
323(1)
20.2 Indications for Surgical Reconstruction
323(2)
20.3 Radiographic Predictors for Ulceration
325(1)
20.4 Timing of Surgery
326(1)
20.5 Preoperative Medical Workup
327(1)
20.6 Glycemic Control
327(1)
20.7 Vitamin D
328(1)
20.8 Renal Function
328(1)
20.9 Procedures/Outcome Studies
328(6)
20.10 Outcomes of Charcot Reconstruction
334(1)
20.11 Summary of Evidence Based Recommendations
335(1)
References
336(9)
21 Amputation in the Diabetic Foot 345(18)
Michael S. Pinzur
Adam P. Schiff
21.1 Introduction
345(1)
21.2 Impediments to Rehabilitation in the Diabetic Amputee
345(1)
21.3 The Lower Extremity as an Organ of Weight Bearing
346(1)
21.4 Metabolic Cost of Walking with an Amputation
346(1)
21.5 Limb Salvage vs. Amputation
347(1)
21.6 Amputation Level Selection
348(1)
21.7 The Terminal Organ of Weight Bearing
348(3)
21.8 The Soft Tissue Envelope
351(1)
21.9 Tissue Management
351(1)
21.10 Outcomes-Following Amputation
352(1)
21.11 Surgical Amputation Levels
352(1)
21.12 Lesser Toe Amputation
353(1)
21.13 Ray Resection
353(2)
21.14 Midfoot Amputation
355(1)
21.15 Hindfoot Amputation
355(1)
21.16 Symes's Ankle Disarticulation Amputation
356(1)
21.17 Transtibial Amputation
357(2)
21.18 Knee Disarticulation Amputation
359(1)
21.19 Transfemoral Amputation
359(1)
21.20 Conclusions
360(1)
References
360(3)
22 Rehabilitation of the Amputee 363(12)
Karen Kowalske
Merrine Klakeel
22.1 Lower Limb Amputation and Prosthetics
363(1)
22.2 Foot Amputations
364(1)
22.3 Foot Orthotics
365(1)
22.4 Transtibial Amputations
366(3)
22.5 Ankle/Foot Components
369(3)
22.6 Conclusion
372(1)
References
372(3)
23 Surgery for the Diabetic Foot: Prophylactic and Osteomyelitis Surgery - Is there an Evidence Base? 375(20)
Javier Aragon-Sanchez
23.1 The Role of Surgery Preventing Occurrence and Recurrence of Foot Ulcers
376(1)
23.2 Preoperative Care
376(1)
23.3 Hallux and First Metatarsal Head Procedures
377(3)
23.4 Lesser Toes
380(1)
23.5 Lesser Metatarsal Heads
381(2)
23.6 Tendon Achilles Lengthening
383(2)
23.7 Curative Surgery for Treating Diabetic Foot Osteomyelitis
385(1)
23.8 Surgery of Forefoot Osteomyelitis
386(2)
23.9 Surgery of Midfoot Osteomyelitis
388(1)
23.10 Surgery of Rear Foot Osteomyelitis
388(1)
References
389(6)
24 Footwear and Orthoses for People with Diabetes 395(14)
J.S. Ulbrecht
S.A. Bus
24.1 Introduction
395(1)
24.2 What is a Therapeutic Shoe for a Person Living with Diabetes?
395(7)
24.3 Who Needs Therapeutic Shoes?
402(1)
24.4 Choosing the Appropriate Footwear for the Patient with LOPS
403(3)
24.5 Summary and Future Trends
406(1)
References
406(3)
25 The Diabetic Foot in Remission 409(8)
Tanzim Khan
Sicco A. Bus
Andrew J.M. Boulton
David G. Armstrong
25.1 The Diabetic Foot in Remission
409(1)
25.2 Maintaining Remission
410(3)
25.3 Conclusion
413(1)
References
414(3)
26 Setting up a Diabetic Foot Clinic 417(12)
Michael E. Edmonds
N.L. Petrova
26.1 Natural History of the Diabetic Foot
417(1)
26.2 Principles of Care of the Diabetic Foot
418(1)
26.3 Space for the Diabetic Foot Clinic
418(1)
26.4 Personnel for the Diabetic Foot Clinic
419(3)
26.5 Organisation of the Diabetic Foot Clinic
422(4)
26.6 Conclusion
426(1)
References
426(3)
27 National Audit of Diabetic Foot Care: Continuing Audit Is Essential for the Delivery of Optimal Care of Diabetic Foot Ulcers 429(10)
William Jeffcoate
Gerry Rayman
Bob Young
27.1 Why Should We Document the Outcome of Routine Care?
429(1)
27.2 General Principles of Clinical Audit
430(3)
27.3 National Diabetes Foot Care Audit of England and Wales
433(4)
References
437(2)
28 Regenerative Medicine and the Diabetic Foot 439(18)
Zachary A. Stern-Buchbinder
Babak Hajhosseini
Geoffrey C. Gurtner
28.1 Introduction
439(1)
28.2 Stem Cells
439(3)
28.3 Diabetes and Healing Impairment
442(1)
28.4 Diabetes and Vascular Dysfunction
443(3)
28.5 Functional Heterogeneity of Stem Cells
446(1)
28.6 Advances in Regenerative Therapy
447(2)
28.7 Conclusion
449(1)
References
449(8)
29 Role of the Plastic Surgeon in Diabetic Foot Care 457(16)
Joon Pio Hong
Hyunsuk Peter Suh
29.1 Introduction
457(1)
29.2 Multidisciplinary Approach and the Spectrum of Care
458(1)
29.3 Reconstruction Algorithm
459(1)
29.4 Debridement (this Is Covered in Detail in another
Chapter)
460(1)
29.5 Evaluating and Enhancing the Vascular Status
461(1)
29.6 Skin Grafts and Substitutes
462(1)
29.7 Local Flaps
463(1)
29.8 Free Flaps
464(2)
29.9 Amputation
466(1)
29.10 Conclusion
467(2)
References
469(4)
30a Algorithms for Diabetic Foot Care: Management of the Hot Swollen Foot 473(8)
Michael E. Edmonds
Chris Manu
Nina Petrova
References
480(1)
30b Approach to a New Diabetic Foot Ulceration 481(14)
Prashanth R.J. Vas
Michael E. Edmonds
30b.1 Introduction
481(1)
30b.2 Clinical Care for the Management of DFU
482(3)
30b.3 Management of DFU
485(5)
30b.4 Structural Care Process in DFU Management
490(1)
References
491(4)
30c Algorithms for Diabetic Foot Care: Vascular Evaluation 495(12)
G. Dovell
R.J. Hinchliffe
30c.1 Introduction
495(1)
30c.2 Methods of Vascular Evaluation - Detecting Peripheral Artery Disease
496(2)
30c.3 Vascular Imaging
498(2)
30c.4 Conclusions
500(3)
References
503(4)
30d Algorithms for Diagnosis and Management of Infection in the Diabetic Foot 507(8)
Edgar J.G. Peters
Benjamin A. Lipsky
30d.1 Diagnosis of Infection
507(2)
30d.2 Therapy of Infection
509(5)
References
514(1)
Index 515
Professor Andrew J. M. Boulton, Division of Diabetes, Endocrinology and Gastroenterology, University of Manchester, Manchester, UK; Consultant Physician, Manchester Royal Infirmary, Manchester, UK; Visiting Professor, Diabetes Research Institute, University of Miami, Miami, FL, USA.

Professor Gerry Rayman, The Diabetes Centre, Ipswich Hospital, Ipswich, UK; University of East Anglia, Norwich, UK; University of Suffolk, Ipswich, UK.

Dr. Dane K. Wukich, Professor and Chair, Department of Orthopaedic Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Permanent link: https://www.kriso.lv/db/9781119445821_pe.html
Keywords: